Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Dec 14;274(3):372–382. doi: 10.1016/j.taap.2013.11.023

Table 2. Effects of antioxidants on the inhibitory effects of DZ and DZO on neurite outgrowth.

Treatment Longest neurite length
(μm)
Minor neurite length
(μm)
No. neurites/cell
Control 140.3 ± 6.8 22.0 ± 0.7 4.7 ± 0.1
PBN 172.4 ± 15.4 13.5 ± 0.7# 5.0 ± 0.2
Mel 149.7 ± 15.5 21.0 ± 1.4 4.1 ± 0.2
DZ 64.8 ± 3.0# 15.5 ± 0.4# 4.6 ± 0.1
DZ + PBN 210.5 ± 20.4# 15.7 ± 0.9# 5.5 ± 0.4
DZ + Mel 175.3 ± 15.6 16.2 ± 0.8# 4.6 ± 0.2
DZO 51.8 ± 2.3# 15.6 ± 0.5# 4.6 ± 0.2
DZO + PBN 188.1 ± 21.8* 20.3 ± 1.1* 5.4 ± 0.3
DZO + Mel 138.2 ± 12.2 16.8 ± 1.2# 4.7 ± 0.2

Astrocytes were pre-treated with 200 μM melatonin (Mel) or 100 μM PBN for 3 h prior to washout and treatment with 10 μM DZ or DZO for 24 h. After further wash-out, astrocytes were co-cultured with hippocampal neurons for 48 h, as described in Methods. Results represent the mean (± SEM) of at least 60 cells per treatment group. Significantly different from untreated control,

*

, p<0.05;

#

, p<0.001.